Impact of antivenom administration on the evolution of cutaneous lesions in loxoscelism: A prospective observational study
Authors: Ceila M S Malaque, Christina T G Novaes, Roberta O Piorelli, Jose Y Risk, Jefferson C Murad, Amanda N Lara, Cristiana C Virgulino, Karina T Miyaji, Marcelo L Santoro
Journal: PLOS Neglected Tropical Diseases
Accepted: 2022-09-23T00:00:00Z

Background: Spiders of the genus Loxosceles are distributed throughout tropical and temperate regions worldwide. Loxosceles spp. bites may evolve to necrosis, with or without intravascular hemolysis. There is no consensus regarding the best treatment to prevent necrosis. The objective of this study was to evaluate the factors associated with the development of necrosis and the impact that antivenom administration has on the evolution of cutaneous loxoscelism. Methodology/Principal findings: This was a prospective observational study carried out at a referral center for envenoming. Over a 6-year period, we included 146 patients with a presumptive or definitive diagnosis of loxoscelism. Depending on the symptom severity, a polyvalent anti-arachnid antivenom was administered or not—in 74 cases (50.7%) and 72 cases (49.3%), respectively. Cutaneous and systemic manifestations were assessed at admission and weekly thereafter. Adverse reactions to the antivenom were also evaluated. Cutaneous loxoscelism was observed in 141 cases (96.6%), and the spider was identified in 29 (19.9%). The mean time from bite to antivenom administration was 41.6 ± 27.4 h. After discharge, 130 patients (90.9%) were treated with corticosteroids, antihistamines and analgesics being prescribed as needed. The probability of developing necrosis was significantly lower among the patients who were admitted earlier, as well as among those who received antivenom (p = 0.0245). Among the 74 patients receiving antivenom, early and delayed adverse reactions occurred in seven (9.5%) and four (5.4%), respectively. Local infection was observed only in three (2.3%) of the 128 patients for whom that information was available. Conclusions/Significance: Necrosis after a Loxosceles sp. bite appears to more common when hospital admission is delayed or when antivenom is not administered. In addition, the administration of a polyvalent anti-arachnid antivenom appears to be safe, with a relatively low rate of adverse reactions. Author summary: Spiders of the genus Loxosceles are widely distributed around the world, and their bite may evolve to skin necrosis, a condition known as cutaneous loxoscelism. There is no consensus about the best treatment to avoid necrosis and ulceration. However, experimental studies suggest that the extent of the necrosis can be reduced by approximately 30% if antivenom is administered within the first 48 h after the venom injection. Therefore, we designed a study to follow patients diagnosed with loxoscelism, treated or not treated with antivenom, in order to assess the evolution of the cutaneous lesion. We observed that patients admitted earlier and receiving antivenom ≤ 48 h after the bite were less likely to develop necrosis, suggesting that antivenom administration has a protective effect, especially when administered promptly. Even the patients who received antivenom ≤ 60 h after the bite were less likely to develop a cutaneous ulcer.